Comparison of Two Rapid Assays for the Detection of <i>BRAF</i> V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
Testing for the <i>BRAF</i> mutation is mandatory for the management of patients with locally advanced or metastatic melanoma. Molecular analysis based on DNA sequencing remains the gold-standard method for the screening of the different <i>BRAF</i> mutations. These methods m...
Main Authors: | Elodie Long-Mira, Alexandra Picard-Gauci, Sandra Lassalle, Véronique Hofman, Salomé Lalvée, Virginie Tanga, Katia Zahaf, Christelle Bonnetaud, Virginie Lespinet, Olivier Camuzard, Henri Montaudié, Gilles Poissonnet, Thierry Passeron, Marius Ilié, Paul Hofman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/3/751 |
Similar Items
-
Treatment with BRAF/MEK: inhibitors in mutant BRAF V600E papillary craniopharyngioma
by: Eva Marie Erfurth, et al.
Published: (2024-12-01) -
Identifying a wide range of mutations in the <i>BRAF</i> gene for prescribing targeted drugs for melanoma treatment
by: A. N. Toropovskiy, et al.
Published: (2023-03-01) -
Association of <i>BRAF</i> V600E Mutant Allele Proportion with the Dissemination Stage of Papillary Thyroid Cancer
by: Ivan Blazekovic, et al.
Published: (2024-02-01) -
An Automated Real-Time PCR Assay versus Next-Generation Sequencing in the Detection of <i>BRAF</i> V600 Mutations in Melanoma Tissue Samples
by: Daniela Lenders, et al.
Published: (2024-07-01) -
Digital Papillary Adenocarcinoma: The Detection of Low-Risk Human Papillomaviruses and the <i>BRAF</i> p.V600E Mutation in a Subset of Cases
by: Feifan Chen, et al.
Published: (2024-06-01)